Health

Chinese biotech firm Vazyme to showcase full range of COVID-19 Testing Solutions at Medlab

DUBAI, UAE, June 14, 2021 /PRNewswire/ -- Chinese biotechnology company Vazyme will showcase a rich lineup of products at the 2021 Medlab Middle East, a leading medical laboratory exhibition co-located with Arab Health. The live in-person event is scheduled to take place from 21 to24 June, 2021 a...

2021-06-14 15:00 2847

Bridge Biotherapeutics Announces the Initiation of Patient Dosing in the Proof of Clinical Principle Study for BBT-401, an Investigational Drug for Ulcerative Colitis

SEONGNAM, South Korea, June 13, 2021 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330) announced today the first patient dosing of BBT-401 at mid to high doses in its proof of clinical principle (PoCP) study to examine the drug's efficacy and safety in active ulcerative colitis (NCT04596293). Th...

2021-06-14 06:00 2663

ImmVira completed the first dosing for Phase II of MVR-T3011 (intratumoral injection) in the U.S. and China

  SHENZHEN, China, June 11, 2021 /PRNewswire/ -- ImmVira announced that in the Phase II Clinical Trials of its leading oncolytic virus product, MVR-T3011* as intratumoral administration (MVR-T3011 IT), ImmVira has completed the first dosing in bothChina and the U.S. on May 28 2021 and June 11 20...

2021-06-12 11:16 3683

United Imaging Splashes Out at SNMMI 2021 With Clinical and Preclinical Technologies, Total-body AI, and Award-Winning Business Programs

HOUSTON, June 11, 2021 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment celebrating its tenth anniversary, announced a number of featured products and is highlighting several distinguished speakers at this year's SNMMI, where it is a Silver S...

2021-06-11 20:10 2371

Concord Medical Officially Opens New Specialty Cancer Hospital in Guangzhou

BEIJING, June 11, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone ...

2021-06-11 18:11 14577

Yingli Pharma Announces a presentation on the Phase 2 clinical trial of linperlisib, a PI3Kδ selective inhibitor, in relapsed or refractory follicular lymphoma at the European Hematology Association 2021 Congress

SHANGHAI, June 11, 2021 /PRNewswire/ -- Shanghai Yingli Pharmaceuticals Ltd (Yingli Pharma), a clinical stage pharmaceutical company providing new therapies for cancer and metabolic diseases, announced today the topline data from a clinical trial sponsored by the company at the annual meeting of ...

2021-06-11 13:05 3074

OliPass Expands Scientific Advisory Board by Inviting Experts in Pain To Bolster Phase 2 Clinical Trial Design and Management

SEOUL, South Korea, June 10, 2021 /PRNewswire/ -- OliPass Corporation, a South Korea based biotech specialized in the development of RNA therapeutics, announced that it is expanding its Scientific Advisory Board ("SAB") for SCN9A antisense pain killer OLP-1002 to include ProfessorPatrick M. Do...

2021-06-10 21:00 1889

Happiness Biotech Entered Into Electric Vehicle Distribution Agreement With Geely's Subsidiary

NANPING, China, June 10, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer and e-commerce services provider, announced today that Taochejun (Fujian) Automobile Distribution Co., Ltd. ("Taoc...

2021-06-10 21:00 12767

VinBrain and FIT Jointly Release a White Paper on Utilizing Artificial Intelligence in Tuberculosis Screening

HANOI, Vietnam, June 10, 2021 /PRNewswire/ -- On June 10, 2021, VinBrain (Vingroup) and FIT (a German NGO working in the field of Tuberculosis prevention and control) jointly release a white paper on utilizing artificial intelligence (AI) in Tuberculosis (TB) diagnosis and screening inVietnam. Th...

2021-06-10 17:11 2270

Verona Pharma and Nuance Pharma Announce $219 Million Strategic Collaboration to Develop and Commercialize Ensifentrine in Greater China

LONDON and RALEIGH, N.C., and SHANGHAI, June 10, 2021 /PRNewswire/ -- Verona Pharma plc (Nasdaq: VRNA) ("Verona Pharma") and Nuance Pharma Limited ("Nuance Pharma"), today announce that the companies have entered into an agreement granting Nuance Pharma, aShanghai-based specialty pharmaceutical c...

2021-06-10 14:00 2935

Peijia Medical Partners with inQB8 for US Incubator and Transcatheter Tricuspid Replacement (TTVR) Product

SUZHOU, China, June 9, 2021 /PRNewswire/ -- Peijia Medical (HKEX:9996, or " Peijia"), a leading player in China for medical technology, announced a partnership withinQB8, a Boston based medical technology incubator, to explore innovative solutions for Structural Heart Disease. This partnership inc...

2021-06-10 10:26 20007

Travecta Therapeutics Appoints Charles S. Ryan as President and Chief Executive Officer

SINGAPORE, June 9, 2021 /PRNewswire/ -- Travecta Therapeutics, Pte Ltd., a preclinical stage biopharmaceutical company pioneering a portfolio of product candidates engineered to cross the blood-brain-barrier, today announced the appointment ofCharles S. Ryan, JD, PhD as President and Chief Execut...

2021-06-09 21:00 2085

China Pharma to Launch Highly Purified NMN+PQQ Product

HAIKOU, China, June 9, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced plans to launch a highly purified NMN+PQQ product following the recent successful completion of a pilot scale ...

2021-06-09 20:00 10422

Summit Healthcare Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering

HONG KONG, June 9, 2021 /PRNewswire/ -- Summit Healthcare Acquisition Corp. (the "Company") today announced the pricing onJune 8, 2021 of its initial public offering of 20,000,000 units at a price of$10.00 per unit. The units will be listed on the Nasdaq Capital Market and trade under the ticker ...

2021-06-09 19:17 19519

Waterdrop Inc. to Report First Quarter 2021 Financial Results on June 17, 2021

BEIJING, June 9, 2021 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it will report its unaudited financial results for the first quarter end...

2021-06-09 19:15 19332

Study of Paxalisib in Primary CNS Lymphoma at Dana-Farber Cancer Institute Enrols First Patient

SYDNEY, June 7, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that a phase II study of Kazia's investigational new drug, paxalisib, in primary CNS lymphoma has been initiated at Dana-Farber Cancer Ins...

2021-06-07 20:00 7387

USANA Malaysia once again named No. 1 combination dietary supplements brand in the country by leading market research company

USANA Malaysia honored by Euromonitor International for third year in a row KUALA LUMPUR, Malaysia, June 6, 2021 /PRNewswire/ -- To be recognized as the top company in your industry is an honor few ever achieve—one USANA Malaysia has now earned for the third year in a row. USANA was recently nam...

2021-06-07 10:22 12023
1 ... 320321322323324